High CTLA-4 gene expression is an independent good prognosis factor in breast cancer patients, especially in the HER2-enriched subtype
Preprint in Research Square (January 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Preprint in Research Square (January 2024)
Article in Frontiers in Genetics (February 2022)
Article in Chemical Biology & Drug Design (January 2022)